Peripheral neuropathy as the presenting feature of tyrosinaemia type I and effectively treated with an inhibitor of 4-hydroxyphenylpyruvate dioxygenase

Gibbs, T C; Payan, J; Brett, E M; Lindstedt, S; Holme, E; Clayton, P T
October 1993
Journal of Neurology, Neurosurgery & Psychiatry;Oct1993, Vol. 56 Issue 10, p1129
Academic Journal
journal article
No abstract available.


Related Articles

  • Nitisinone: Ntbc, Orfadin.  // Drugs in R&D;2002, Vol. 3 Issue 2, p139 

    Adis Comments Nitisinone [NTBC] was originally developed as a herbicide but is now in phase III clinical trials in Sweden and the United Kingdom for the treatment of tyrosinaemia type I. Treatment has been successful in 87% of patients with acute tyrosinaemia who were treated before 6 months of...

  • Nitisinone.  // Reactions Weekly;8/10/2013, Issue 1465, p28 

    An abstract of the article "Corneal depositions in tyrosinaemia type I during treatment with Nitisinone," by R.P. Wisse and colleagues, is presented.

  • HPPDs losing battle against waterhemp. Flint, Josh // Mid-South Farmer;Jun2011, Vol. 16 Issue 6, p10 

    The article offers information on the ineffeciency of hydroxyphenylpyruvate dioxygenase (HPPD)-inhibitor herbicides in controlling waterhemp.

  • Nitisinone.  // Reactions Weekly;02/09/2013, Issue 1438, p23 

    The article presents a case study of a 16-year-old boy who developed corneal crystals while he was treated with nitisinone for type 1 tyrosinaemia.

  • COMPLICATIONS--NEUROPATHY.  // Diabetes;Jun2008 Supplement 1, Vol. 57, pA635 

    The article presents abstracts of research related to neuropathy and diabetes which include the use of nutrinerve in treating diabetic peripheral neuropathy, cardiac autonomic dysfunction and chronic peripheral neuropathy in postmenopausal diabetic women, and the effect of estrogen-progestin...

  • A Breakthrough in Using Light Therapy to Treat Neuropathies. Saputo, Len // Townsend Letter;Nov2015, Issue 388, p74 

    The article presents three case histories to illustrate the peripheral neuopathies that can be treated with light therapy. Topics include chemotherapy-induced peripheral neuropathy, trauma-induced neuropathy, and diabetic neuropathy. Also mentioned are neuropathic pain, pain management, and...

  • A novel therapeutic trial of homogentisic aciduria in a murine model of alkaptonuria. Suzuki, Yasuyo; Oda, Kazumi; Yoshikawa, Yasuji; Maeda, Toyoki; Suzuki, T. // Journal of Human Genetics;1999, Vol. 44 Issue 2, p79 

    Abstract Alkaptonuria is a rare autosomal recessive disorder characterized by homogentisic aciduria, ochronosis, and arthritis. Although a deficiency of homogentisic acid 1,2dioxygenase has recently been confirmed at the molecular level, no effective treatment regimen has yet been developed for...

  • Waterhemp herbicide resistance grows.  // Nebraska Farmer;Apr2011, Vol. 153 Issue 4, p43 

    The article focuses on the article published by the University of Illinois (U of I) researchers entitled "Pest Management Science," which confirms that waterhemp is the first weed that resists the hydroxyphenylpyruvate dioxygenase (HPPD) inhibiting herbicides.

  • Criteria for the diagnosis of peripheral neuropathies. Horowitz, S.H. // Occupational & Environmental Medicine;Jul2002, Vol. 59 Issue 7, p425 

    Editorial. Focuses on the diagnosis of peripheral neuropathies. Types of peripheral neuropathies; Methodology for the diagnosis of peripheral neuropathies; Validity of the diagnostic methods.

  • neuropathy.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1575 

    A definition of the term "neuropathy" is presented. It refers to any disease of the nerves. Definitions of various types of neuropathy are also presented, including AIDS peripheral neuropathy, auditory neuropathy, multifocal motor neuropathy, optic neuropathy and subacute myelo-optic,...


Read the Article


Sign out of this library

Other Topics